Status:
RECRUITING
"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Conditions:
Hepatitis B， Chronic
Eligibility:
All Genders
Brief Summary
Hepatitis B virus (HBV) infection remains one of the most serious health problems worldwide. Patients with chronic HBV infection are at an increased risk for developing hepatic cirrhosis, hepatocellul...
Eligibility Criteria
Inclusion Criteria:
- Patients with chronic HBV infection (defined as HBsAg positive for at least 6 months)
Exclusion Criteria:
- Co-infection with human immunodeficiency virus (HIV), hepatitis C virus (HCV) and/or hepatitis D virus (HDV)
- History of liver transplantation
- History of hepatocellular carcinoma (HCC)
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT03097952
Start Date
January 1 2008
End Date
December 1 2030
Last Update
March 31 2017
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
The Third Hospital of Changzhou
Changzhou, Jiangsu, China, 213001
2
Huai'an No.4 People's Hospital
Huai'an, Jiangsu, China, 223300
3
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China, 210008
4
Nanjing Jiangbei People's Hospital
Nanjing, Jiangsu, China, 210048